nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.354	0.397	CbGeAlD
Cyamemazine—HTR2A—trigeminal nerve—multiple sclerosis	0.093	0.104	CbGeAlD
Cyamemazine—HTR2A—pons—multiple sclerosis	0.0655	0.0734	CbGeAlD
Cyamemazine—HTR2A—pineal body—multiple sclerosis	0.0468	0.0524	CbGeAlD
Cyamemazine—HTR2A—peripheral nervous system—multiple sclerosis	0.0436	0.0488	CbGeAlD
Cyamemazine—HTR2A—nerve—multiple sclerosis	0.034	0.0381	CbGeAlD
Cyamemazine—HTR2C—brainstem—multiple sclerosis	0.0291	0.0326	CbGeAlD
Cyamemazine—HTR2C—medulla oblongata—multiple sclerosis	0.0203	0.0227	CbGeAlD
Cyamemazine—HTR2C—midbrain—multiple sclerosis	0.0185	0.0208	CbGeAlD
Cyamemazine—HTR2C—spinal cord—multiple sclerosis	0.0181	0.0202	CbGeAlD
Cyamemazine—CHRM2—nervous system—multiple sclerosis	0.0158	0.0177	CbGeAlD
Cyamemazine—HTR2C—nervous system—multiple sclerosis	0.0152	0.0171	CbGeAlD
Cyamemazine—CHRM2—central nervous system—multiple sclerosis	0.0152	0.017	CbGeAlD
Cyamemazine—HTR2C—central nervous system—multiple sclerosis	0.0147	0.0164	CbGeAlD
Cyamemazine—HTR2A—brainstem—multiple sclerosis	0.0146	0.0163	CbGeAlD
Cyamemazine—HTR2A—retina—multiple sclerosis	0.0141	0.0158	CbGeAlD
Cyamemazine—CHRM2—brain—multiple sclerosis	0.0121	0.0135	CbGeAlD
Cyamemazine—HTR2C—brain—multiple sclerosis	0.0116	0.013	CbGeAlD
Cyamemazine—HTR2A—medulla oblongata—multiple sclerosis	0.0102	0.0114	CbGeAlD
Cyamemazine—HTR2A—midbrain—multiple sclerosis	0.00929	0.0104	CbGeAlD
Cyamemazine—HTR2A—spinal cord—multiple sclerosis	0.00907	0.0102	CbGeAlD
Cyamemazine—HTR2A—nervous system—multiple sclerosis	0.00764	0.00856	CbGeAlD
Cyamemazine—HTR2A—central nervous system—multiple sclerosis	0.00736	0.00824	CbGeAlD
Cyamemazine—HTR2A—cerebellum—multiple sclerosis	0.00719	0.00805	CbGeAlD
Cyamemazine—HTR2A—brain—multiple sclerosis	0.00584	0.00654	CbGeAlD
Cyamemazine—Ethopropazine—BCHE—multiple sclerosis	0.00517	0.284	CrCbGaD
Cyamemazine—Triflupromazine—BCHE—multiple sclerosis	0.00423	0.232	CrCbGaD
Cyamemazine—Chlorpromazine—BCHE—multiple sclerosis	0.00204	0.112	CrCbGaD
Cyamemazine—Acepromazine—ALB—multiple sclerosis	0.00161	0.0882	CrCbGaD
Cyamemazine—Thioproperazine—ALB—multiple sclerosis	0.00157	0.0862	CrCbGaD
Cyamemazine—Pipotiazine—ALB—multiple sclerosis	0.00155	0.0848	CrCbGaD
Cyamemazine—Clomipramine—ALB—multiple sclerosis	0.00122	0.0671	CrCbGaD
Cyamemazine—Chlorpromazine—ALB—multiple sclerosis	0.000838	0.046	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00025	0.00281	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000249	0.00279	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CNR1—multiple sclerosis	0.000248	0.00279	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—S1PR1—multiple sclerosis	0.000248	0.00278	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—RGS1—multiple sclerosis	0.000247	0.00278	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—PTGER4—multiple sclerosis	0.000244	0.00274	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000244	0.00274	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCR3—multiple sclerosis	0.00024	0.0027	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000236	0.00265	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000236	0.00265	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCR1—multiple sclerosis	0.000236	0.00265	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000236	0.00265	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GPR65—multiple sclerosis	0.000234	0.00263	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCR2—multiple sclerosis	0.000234	0.00262	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—RGS1—multiple sclerosis	0.000232	0.00261	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000231	0.00259	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCR2—multiple sclerosis	0.00023	0.00258	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000228	0.00256	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000227	0.00254	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LINGO1—multiple sclerosis	0.000227	0.00254	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000224	0.00252	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CXCL10—multiple sclerosis	0.000224	0.00251	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00022	0.00247	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00022	0.00246	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CNR1—multiple sclerosis	0.000216	0.00242	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000216	0.00242	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—RGS1—multiple sclerosis	0.000215	0.00241	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCL13—multiple sclerosis	0.000214	0.00241	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCR1—multiple sclerosis	0.000214	0.00241	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000214	0.0024	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	0.000212	0.00238	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	0.000211	0.00237	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000205	0.0023	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000205	0.0023	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GPR65—multiple sclerosis	0.000204	0.00228	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000201	0.00226	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000201	0.00226	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.0002	0.00225	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	0.0002	0.00224	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000198	0.00222	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LINGO1—multiple sclerosis	0.000197	0.00221	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000197	0.00221	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TAGAP—multiple sclerosis	0.000197	0.00221	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000194	0.00218	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000194	0.00218	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	0.000193	0.00217	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CCL5—multiple sclerosis	0.000193	0.00216	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	0.000191	0.00214	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000191	0.00214	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCR1—multiple sclerosis	0.000186	0.00209	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000186	0.00209	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000186	0.00208	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	0.000183	0.00205	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000183	0.00205	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000178	0.002	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000174	0.00196	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CCR5—multiple sclerosis	0.000173	0.00195	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—S1PR1—multiple sclerosis	0.000172	0.00193	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TAGAP—multiple sclerosis	0.000171	0.00192	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	0.000168	0.00188	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCL5—multiple sclerosis	0.000167	0.00188	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GPC5—multiple sclerosis	0.000167	0.00188	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	0.000164	0.00184	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000162	0.00182	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000156	0.00176	CbGpPWpGaD
Cyamemazine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000155	0.00174	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000155	0.00174	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL3—multiple sclerosis	0.000153	0.00171	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCR2—multiple sclerosis	0.000152	0.00171	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000152	0.0017	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000151	0.0017	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCR5—multiple sclerosis	0.000151	0.00169	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—S1PR1—multiple sclerosis	0.000149	0.00167	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000149	0.00167	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	0.000148	0.00166	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PTGER4—multiple sclerosis	0.000147	0.00165	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	0.000146	0.00164	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RGS1—multiple sclerosis	0.000146	0.00164	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000145	0.00163	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GPC5—multiple sclerosis	0.000145	0.00163	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000143	0.0016	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	0.000142	0.0016	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCR3—multiple sclerosis	0.000142	0.00159	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000141	0.00158	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CNR1—multiple sclerosis	0.00014	0.00158	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GPR65—multiple sclerosis	0.000138	0.00155	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCR2—multiple sclerosis	0.000138	0.00155	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000138	0.00155	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000136	0.00153	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000136	0.00152	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—POMC—multiple sclerosis	0.000136	0.00152	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000133	0.0015	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CCL2—multiple sclerosis	0.000133	0.00149	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL3—multiple sclerosis	0.000133	0.00149	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000132	0.00148	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	0.00013	0.00146	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	0.00013	0.00146	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000128	0.00143	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CNR1—multiple sclerosis	0.000127	0.00143	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RGS1—multiple sclerosis	0.000127	0.00142	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL13—multiple sclerosis	0.000127	0.00142	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCR1—multiple sclerosis	0.000127	0.00142	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000126	0.00142	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000125	0.00141	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	0.000125	0.0014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000123	0.00138	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000122	0.00137	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000121	0.00136	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GPR65—multiple sclerosis	0.00012	0.00135	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCR2—multiple sclerosis	0.00012	0.00135	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00012	0.00134	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000118	0.00133	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	0.000118	0.00133	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	0.000118	0.00132	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—POMC—multiple sclerosis	0.000118	0.00132	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000117	0.00132	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	0.000116	0.0013	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000115	0.00129	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000115	0.00129	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	0.000115	0.00129	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	0.000113	0.00127	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CNR1—multiple sclerosis	0.000111	0.00124	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL13—multiple sclerosis	0.00011	0.00123	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCR1—multiple sclerosis	0.00011	0.00123	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00011	0.00123	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	0.000109	0.00122	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	0.000109	0.00122	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	0.000108	0.00121	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	0.000108	0.00121	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000108	0.00121	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000104	0.00117	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	9.97e-05	0.00112	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	9.88e-05	0.00111	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	9.8e-05	0.0011	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	9.79e-05	0.0011	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	9.66e-05	0.00108	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	9.45e-05	0.00106	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	9.28e-05	0.00104	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	9.07e-05	0.00102	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	9.02e-05	0.00101	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	8.9e-05	0.000999	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	8.77e-05	0.000985	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	8.69e-05	0.000975	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	8.58e-05	0.000963	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PGR—multiple sclerosis	8.56e-05	0.00096	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	8.51e-05	0.000956	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	8.43e-05	0.000946	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	8.39e-05	0.000942	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	8.39e-05	0.000942	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	8.36e-05	0.000938	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CD28—multiple sclerosis	8.31e-05	0.000933	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	8.24e-05	0.000925	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	8.16e-05	0.000916	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	7.84e-05	0.00088	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	7.73e-05	0.000868	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	7.69e-05	0.000864	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	7.66e-05	0.00086	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	7.62e-05	0.000855	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	7.59e-05	0.000852	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	7.54e-05	0.000847	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	7.53e-05	0.000845	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	7.48e-05	0.00084	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PGR—multiple sclerosis	7.43e-05	0.000834	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	7.41e-05	0.000831	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	7.29e-05	0.000819	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	7.29e-05	0.000818	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CD28—multiple sclerosis	7.22e-05	0.00081	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	7.15e-05	0.000803	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	7.09e-05	0.000795	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	7.09e-05	0.000795	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	6.96e-05	0.000781	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	6.96e-05	0.000781	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	6.81e-05	0.000764	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	6.78e-05	0.000761	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	6.65e-05	0.000747	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	6.54e-05	0.000734	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	6.53e-05	0.000733	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	6.42e-05	0.000721	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	6.18e-05	0.000694	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	6.04e-05	0.000678	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	5.93e-05	0.000666	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	5.93e-05	0.000666	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	5.91e-05	0.000664	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	5.89e-05	0.000661	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	5.84e-05	0.000655	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	5.8e-05	0.000652	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	5.78e-05	0.000649	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	5.66e-05	0.000636	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	5.41e-05	0.000607	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	5.37e-05	0.000603	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	5.27e-05	0.000592	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	5.26e-05	0.00059	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	5.18e-05	0.000582	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	5.15e-05	0.000578	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	5.14e-05	0.000577	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	5.07e-05	0.000569	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	5.06e-05	0.000567	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	4.98e-05	0.000559	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	4.92e-05	0.000552	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	4.83e-05	0.000542	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	4.78e-05	0.000537	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	4.69e-05	0.000527	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	4.61e-05	0.000517	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	4.57e-05	0.000513	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	4.5e-05	0.000505	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	4.48e-05	0.000503	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	4.47e-05	0.000501	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	4.42e-05	0.000496	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	4.39e-05	0.000492	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	4.33e-05	0.000486	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	4.15e-05	0.000466	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	4.11e-05	0.000461	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	4.08e-05	0.000458	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	4.02e-05	0.000451	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	3.93e-05	0.000442	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	3.76e-05	0.000422	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	3.69e-05	0.000414	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	3.65e-05	0.00041	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	3.57e-05	0.000401	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	3.5e-05	0.000393	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	3.49e-05	0.000392	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	3.43e-05	0.000385	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	3.42e-05	0.000384	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	3.35e-05	0.000377	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	3.17e-05	0.000356	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	3.11e-05	0.000349	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	3.04e-05	0.000341	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	3.02e-05	0.000339	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	2.88e-05	0.000323	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	2.64e-05	0.000296	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	2.63e-05	0.000295	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	2.59e-05	0.000291	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	2.58e-05	0.000289	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	2.56e-05	0.000287	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	2.5e-05	0.00028	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	2.45e-05	0.000275	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	2.38e-05	0.000267	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	2.37e-05	0.000266	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	2.32e-05	0.000261	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	2.22e-05	0.000249	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	2.18e-05	0.000245	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	2.06e-05	0.000232	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	2.06e-05	0.000231	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	2.03e-05	0.000227	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	2.02e-05	0.000227	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	2.02e-05	0.000227	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	1.98e-05	0.000222	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	1.79e-05	0.0002	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	1.55e-05	0.000174	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	1.52e-05	0.000171	CbGpPWpGaD
